Abstract
Aim:
We investigated the effect of elevated plasma free fatty acid and insulin concentrations on PDK4 mRNA transcript and protein content and long-chain acyl-coenzyme A accumulation in human skeletal muscle.
Methods:
On two occasions, 10 healthy men underwent hyperinsulinemic-euglycemic clamps for 6 h with (LIPID) and without (CON) iv Intralipid (20% at 90 ml/h) plus heparin (200 U prime + 600 U/h) infusion.
Results:
Glucose disposal was approximately 50% lower at the end of the clamp in the LIPID compared with the CON trial (37.8 +/- 4.4 and 79.6 +/- 4.0 micromol/kg lean mass.min, respectively; P < 0.01). In the LIPID trial, muscle long-chain acyl-coenzyme A concentration increased after 6 h, but not 3 h of lipid infusion (P < 0.01). Muscle PDK4 mRNA, but not protein, was down-regulated by 2-fold within 3 h in both clamps and decreased further (6-fold; P < 0.01) at 6 h in the CON but not the LIPID clamp. The lipid-induced attenuation in the suppression of PDK4 gene expression was not dependent on the activation of the Akt/FOXO3 pathway.
Conclusion:
Accumulation of im lipids plays a more important role than impaired activation of Akt-mediated pathways in the regulation of muscle PDK4 gene expression in lipid-induced acute insulin-resistant states.
Publication types
-
Randomized Controlled Trial
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Acetylcarnitine / metabolism
-
Acyl Coenzyme A / metabolism*
-
Adult
-
Carbohydrate Metabolism / drug effects
-
Carbohydrate Metabolism / physiology
-
Fat Emulsions, Intravenous / pharmacology
-
Fatty Acids / blood*
-
Forkhead Box Protein O3
-
Forkhead Transcription Factors / metabolism
-
Gene Expression Regulation, Enzymologic / drug effects
-
Gene Expression Regulation, Enzymologic / physiology
-
Glucose Clamp Technique
-
Humans
-
Hyperinsulinism / physiopathology
-
Hypoglycemic Agents / administration & dosage
-
Hypoglycemic Agents / blood*
-
Insulin / administration & dosage
-
Insulin / blood*
-
Insulin Resistance / physiology
-
Male
-
Muscle, Skeletal / drug effects
-
Muscle, Skeletal / enzymology*
-
Oxidation-Reduction / drug effects
-
Protein Serine-Threonine Kinases / genetics*
-
Protein Serine-Threonine Kinases / metabolism
-
Proto-Oncogene Proteins c-akt / metabolism
-
Pyruvate Dehydrogenase Acetyl-Transferring Kinase
-
Pyruvate Dehydrogenase Complex / metabolism
-
RNA, Messenger / metabolism
-
Signal Transduction / drug effects
-
Signal Transduction / physiology
Substances
-
Acyl Coenzyme A
-
FOXO3 protein, human
-
Fat Emulsions, Intravenous
-
Fatty Acids
-
Forkhead Box Protein O3
-
Forkhead Transcription Factors
-
Hypoglycemic Agents
-
Insulin
-
PDK4 protein, human
-
Pyruvate Dehydrogenase Acetyl-Transferring Kinase
-
Pyruvate Dehydrogenase Complex
-
RNA, Messenger
-
Acetylcarnitine
-
Protein Serine-Threonine Kinases
-
Proto-Oncogene Proteins c-akt